Evaluation of Transnasal Endoscopy During COVID-19 Pandemic
1 other identifier
interventional
500
1 country
1
Brief Summary
Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2021
CompletedStudy Start
First participant enrolled
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
February 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFebruary 2, 2021
January 1, 2021
5 months
January 13, 2021
January 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Questionnaire
a questionnaire with 5 questions regarding the quality of the examination, technique and safety is presented to the patients
after examination, about 15 minutes
Study Arms (1)
Gastroscopy in transnasal technique
OTHERAll patients with indication for gastroscopy in transnasal techqiue are included.
Interventions
All patients with indication for gastroscopy in transnasal technique are included.
Eligibility Criteria
You may qualify if:
- Indication for transnasal endoscopy
You may not qualify if:
- pregnancy
- breast feeding
- contraindication to transnasal endoscopy
- pronounced blood clotting disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Mainz
Mainz, Rhenanie-Palatinate, 55131, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helmut Neumann, M.D. PhD
University Medical Center Mainz
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 13, 2021
First Posted
February 2, 2021
Study Start
January 13, 2021
Primary Completion
June 15, 2021
Study Completion
December 31, 2021
Last Updated
February 2, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share
A publication of the results is planned.